4//SEC Filing
Daniels Mark 4
Accession 0001214659-21-002778
CIK 0001581280other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:15 PM ET
Size
8.8 KB
Accession
0001214659-21-002778
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Exercise/Conversion
Common Stock
2021-03-04$10.70/sh+669$7,158→ 67,595 total - Sale
Common Stock
2021-03-04$125.33/sh−669$83,846→ 66,926 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-04−669→ 6,685 totalExercise: $10.70Exp: 2028-02-01→ Common Stock (669 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753840
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:15 PM ET
- Size
- 8.8 KB